We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-12.7%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$1.17B
AUM Growth
-$1.21B
Cap. Flow
-$1.07B
Cap. Flow %
-90.92%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CAVA icon
CAVA Group
CAVA
+$1.07B

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 91.41%
2 Healthcare 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAVA icon
1
CAVA Group
CAVA
$7.64B
$1.07B 91.41%
9,507,990
-8,000,000
-46% -$1.07B
LXRX icon
2
Lexicon Pharmaceuticals
LXRX
$1.03B
$101M 8.59%
136,180,481

Similar funds

Artal Group's Q4 2024 Portfolio in Review

As of Q4 2024, Artal Group held 2 positions worth $1.17B, down 51% from $2.38B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Artal Group withdrew a net $1.07B in Q4 2024, reducing 1 holding. Its largest reduction was CAVA Group, cutting an estimated $1.07B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 91% of assets, up from 91% a quarter earlier, followed by Healthcare.

  • Artal Group's biggest Q4 2024 reduction was CAVA Group, cutting an estimated $1.07B.
  • Artal Group's ten largest holdings make up 100% of its $1.17B portfolio in Q4 2024.
  • Artal Group opened 0 new positions and closed 0 in Q4 2024.
  • Artal Group's portfolio value fell 51% quarter-over-quarter to $1.17B.

Based on Artal Group's 13F filing for Q4 2024, filed 14 Feb 2025.